v3.26.1
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net Sales $ 2,177.0 $ 2,077.3 $ 4,263.7 $ 3,986.4
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization $ 635.5 $ 592.2 $ 1,211.6 $ 1,142.0
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Intangible asset amortization $ 163.4 $ 160.6 $ 325.5 $ 311.6
Research and development 104.8 113.3 208.2 223.9
Selling, general and administrative 899.3 814.8 1,749.3 1,573.5
Restructuring and other cost reduction initiatives 29.8 17.5 36.1 53.5
Acquisition, integration, divestiture and related 18.1 78.9 33.7 89.5
Operating expenses 1,850.9 1,777.3 3,564.4 3,394.0
Operating Profit 326.1 300.0 699.2 592.3
Other income (expense), net 1.9 3.9 (1.1) 6.9
Interest expense, net (72.9) (79.3) (141.7) (145.5)
Earnings before income taxes 255.1 224.6 556.4 453.6
Provision for income taxes 55.5 71.2 118.5 117.6
Net Earnings 199.6 153.4 437.9 336.0
Less: Net earnings attributable to noncontrolling interest 1.3 0.6 1.5 1.1
Net Earnings of Zimmer Biomet Holdings, Inc. $ 198.3 $ 152.8 $ 436.5 $ 334.9
Earnings Per Common Share        
Basic $ 1.03 $ 0.77 $ 2.25 $ 1.69
Diluted $ 1.03 $ 0.77 $ 2.25 $ 1.68
Weighted Average Common Shares Outstanding        
Basic 192.2 197.9 193.6 198.4
Diluted 192.8 198.3 194.3 199.0